Scientia Vascular Highlights Expanded Neurovascular Collaboration With Medtronic

According to a recent LinkedIn post from Scientia Vascular, the company is highlighting its collaboration with Medtronic Neurovascular to combine its access portfolio with Medtronic’s neurovascular treatment therapies. The post suggests this creates an integrated offering that supports physicians across the full neurovascular procedural workflow.

The LinkedIn post notes that Scientia’s technology was involved in treating 90,000 patients in 2025 and implies that Medtronic’s global scale could increase that reach. For investors, the collaboration points to potential volume growth for Scientia’s product suite, stronger commercial distribution, and a more competitive position in the neurovascular devices segment, though no financial terms or specific revenue projections are mentioned.